School of Medicine

WashU Medicine postdoctoral researchers Wesley Saintilnord and Matthew Reynolds have been named Jane Coffin Childs Fellows. The fellowship is designed to support the most promising postdoctoral scientists as they seek to advance research into the causes and treatments of human disease.

A new study from WashU Medicine researchers identifies possible ways to make cancer drugs called PARP inhibitors more effective, including potential strategies to re-establish their effectiveness in tumors that develop resistance to this treatment.

Tsuyoshi Kaneko, MD, a clinical innovator who has developed new devices and techniques for heart valve surgeries, has been named the new director of the Division of Cardiothoracic Surgery in the Department of Surgery at WashU Medicine.

A new WashU Medicine study led by Bhooma Aravamuthan, MD, DPhil, identifies a standardized way to assess leg dystonia, a painful movement disorder that commonly affects children with cerebral palsy.

A WashU Medicine neuroscientist and fan of the Philadelphia Eagles, Jason Yi, has received a $400,000 grant to study autism spectrum disorder from the football team’s foundation.

WashU Medicine researchers showed that a popular antidepressant drug effectively reduced seizures for two sisters with a rare form of epilepsy.

A WashU Medicine study paves the way to make an effective treatment more accessible to those ‘paralyzed by life.’

WashU scientists are collaborating to unlock secrets of a millennia-old scourge. Efforts may lead to an increased understanding of and improved treatments for tuberculosis, which is once again on the rise.

Eric J. Lenze, MD, and his team at WashU Medicine’s Healthy Mind Lab are among 40 semifinalists in the XPRIZE Healthspan competition awarded $250,000 to study approaches to improve healthy aging.

Hong Chen, a biomedical engineer at WashU, shares the potential for using synthetic torpor technology to develop new treatments for a range of illnesses and injuries.